| 21st week of 2018 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20180140589 | ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS | 2018-05-24 |
| 20180140591 | ORAL DELIVERY VEHICLE CONTAINING NICOTINE | 2018-05-24 |
| 20180140592 | 5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAM- IDE, SALTS AND USES THEREOF | 2018-05-24 |
| 20180140593 | Treatment of Glaucoma Using Laquinimod | 2018-05-24 |
| 20180140594 | TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD | 2018-05-24 |
| 20180140595 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | 2018-05-24 |
| 20180140596 | New Pharmaceutical use and Pharmaceutical composition of pyrroloquinoline quinine, its derivatives and/or its salts | 2018-05-24 |
| 20180140597 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS IN PATIENTS SUFFERING FROM CIRRHOSIS | 2018-05-24 |
| 20180140598 | TREAMENT OF T-CELL MEDIATED DISEASES | 2018-05-24 |
| 20180140599 | PREVENTION AND/OR TREATMENT OF CONTRAST-INDUCED ACUTE KIDNEY INJURY | 2018-05-24 |
| 20180140600 | DEUTERATED DEHYDROPHENYLAHISTIN COMPOUNDS AND PREPARATION METHOD THEREOF AND USE THEREOF IN PREPARATION OF ANTI-TUMOR DRUGS | 2018-05-24 |
| 20180140601 | Neuroprotective Bicyclic Compounds and Methods for Their Use in Treating Autism Spectrum Disorders and Neurodevelopmental Disorders | 2018-05-24 |
| 20180140602 | COMBINATION OF CHIMERIC ANTIGEN RECEPTOR THERAPY AND AMINO PYRIMIDINE DERIVATIVES | 2018-05-24 |
| 20180140603 | POLYMORPHS OF ARRY-380, A SELECTIVE HER2 INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2018-05-24 |
| 20180140604 | METHODS OF DIAGNOSING AND TREATING CANCER | 2018-05-24 |
| 20180140605 | COMPOSITIONS AND METHODS INVOLVING POLYMER, SOLVENT, AND HIGH VISCOSITY LIQUID CARRIER MATERIAL | 2018-05-24 |
| 20180140606 | In Vivo Chemoselection with Low Dose Thioguanine | 2018-05-24 |
| 20180140607 | HYDROXYL PURINE COMPOUNDS AND USE THEREOF | 2018-05-24 |
| 20180140608 | METHOD | 2018-05-24 |
| 20180140609 | USE OF (4-HYDROXY-2-METHYL-1,1-DIOXIDO-2H-BENZO[E][1,2]THIAZINE-3-YL)(NAPH- THALENE-2-YL) METHANONE IN THE PREVENTION AND/OR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | 2018-05-24 |
| 20180140610 | OPIPRAMOL PATCH | 2018-05-24 |
| 20180140611 | Combination Therapy of Cardiac Myosin Activator and Sinus Node If Current Inhibitor | 2018-05-24 |
| 20180140612 | TOPICAL OPHTHALMIC FORMULATIONS FOR THE TREATMENT AND PREVENTION OF MIGRAINE HEADACHE | 2018-05-24 |
| 20180140613 | Metal Delivery Agents and Therapeutic Uses of the Same | 2018-05-24 |
| 20180140614 | CORTICOSTERIOD CONTAINING FOAM COMPOSITIONS | 2018-05-24 |
| 20180140615 | METHOD OF MANUFACTURING CORTICOSTERIOD CONTAINING FOAM COMPOSITIONS | 2018-05-24 |
| 20180140617 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING PERIPHERAL DEMYELINATING DISEASES | 2018-05-24 |
| 20180140618 | ANTICANCER ADJUVANT CONTAINING PANAXADIOL GINSENOCIDE COMPOUND | 2018-05-24 |
| 20180140619 | COMPOSITIONS AND METHODS FOR DELIVERING THERAPEUTIC AGENTS INTO THE COLON | 2018-05-24 |
| 20180140620 | Pharmaceutical Combinations of Organo-Arsenoxide Compounds and mTOR Inhibitors | 2018-05-24 |
| 20180140621 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING ARTHRITIS | 2018-05-24 |
| 20180140622 | NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF | 2018-05-24 |
| 20180140623 | COMPOSITION FOR PREVENTING OR TREATING CERVICAL CANCER INCLUDING GYPENOSIDE LXXV | 2018-05-24 |
| 20180140624 | METHOD FOR IMPROVING KIDNEY AND/OR HEART FUNCTION IN PATIENTS WITH KIDNEY DISEASE | 2018-05-24 |
| 20180140625 | PRODUCTION OF STABLE NON-POLYADENYLATED RNAS | 2018-05-24 |
| 20180140626 | RETINOL-BINDING PROTEIN 3 (RBP3) AS A PROTECTIVE FACTOR IN NON-DIABETIC RETINAL DEGENERATION | 2018-05-24 |
| 20180140627 | OLIGODEOXY NUCLEOTIDE FOR PREPARING DRUGS FOR INHIBITING TUMOR GROWTH AND APPLICATION THEREOF | 2018-05-24 |
| 20180140628 | COMPOSITION INCLUDING GLYCOSAMINOGLYCAN DERIVATIVE AND CHEMOKINE RECEPTOR ACTIVITY REGULATOR | 2018-05-24 |
| 20180140629 | IN VITRO BIO-REACTOR CIRCUIT | 2018-05-24 |
| 20180140630 | COMBINATION OF AN H2-RECEPTOR ANTAGONIST, ANTACID, AND ALGINIC ACID TO TREAT EPISODIC HEARTBURN | 2018-05-24 |
| 20180140631 | AMORPHOUS CALCIUM CARBONATE STABILIZED WITH POLYPHOSPHATES OR BISPHOSPHONATES | 2018-05-24 |
| 20180140632 | NUTRITIONAL SUPPLEMENT FOR GROWTH ENHANCEMENT | 2018-05-24 |
| 20180140633 | METHODS OF TREATING A TREATMENT-RESISTANT GASTROINTESTINAL SPASM WITH AN OXIDIZED TANNIN | 2018-05-24 |
| 20180140634 | ENHANCING THE EFFECT OF CAR-ENGINEERED T CELLS BY MEANS OF NUCLEIC ACID VACCINATION | 2018-05-24 |
| 20180140635 | GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE | 2018-05-24 |
| 20180140636 | EXTRACELLULAR MATRIX FROM PLURIPOTENT CELLS | 2018-05-24 |
| 20180140637 | EPIDERMAL NEURAL CREST STEM CELLS AS A SOURCE OF SCHWANN CELLS | 2018-05-24 |
| 20180140638 | PROCESS FOR PREPARING AN ANIMAL BRAIN EXTRACT | 2018-05-24 |
| 20180140639 | THERAPEUTIC SERUM OBTAINED FROM CO-CULTURED CELLS | 2018-05-24 |
| 20180140640 | IMPROVED CONTRACEPTIVE METHODS AND COMPOSITIONS AND DEVICES FOR USE THEREIN | 2018-05-24 |
| 20180140641 | AMNIOTIC FLUID FORMULATION FOR TREATMENT OF LUNG DISORDERS | 2018-05-24 |
| 20180140642 | MICROVESICLES ISOLATED FROM MESENCHYMAL STEM CELLS FOR USE AS IMMUNOSUPPRESSIVE AGENTS | 2018-05-24 |
| 20180140644 | BEE-INGESTIBLE COMPOSITIONS, METHODS OF USING SAME FOR PRODUCING HONEY AND HONEY PRODUCED THEREBY | 2018-05-24 |
| 20180140645 | PROBIOTIC OR PREBIOTIC, METHOD FOR PRODUCING SAME, MICROBIAL PREPARATION, HEALTH FOOD, AND MEDICINE | 2018-05-24 |
| 20180140646 | FERMENTED COMPOSITION FOR RELIEVING ATOPIC DERMATITIS CONTAINING NATURAL EXTRACTS | 2018-05-24 |
| 20180140647 | Delivery System and Probiotic Composition for Animals and Plants | 2018-05-24 |
| 20180140648 | BACTERIAL POPULATIONS FOR PROMOTING HEALTH | 2018-05-24 |
| 20180140649 | ONCOLYTIC ADENOVIRUS ENCODING A B7 PROTEIN | 2018-05-24 |
| 20180140650 | ISOLATION OF OMEGA-7 FATTY ACID ETHYL ESTERS FROM NATURAL OILS | 2018-05-24 |
| 20180140651 | COMPOSITION FOR PREVENTING OR TREATING LIVER DISEASE COMPRISING POGOSTEMONIS HERBA EXTRACT | 2018-05-24 |
| 20180140652 | HAND WRAP INCLUDING EUCALYPTUS OIL | 2018-05-24 |
| 20180140653 | COMPOSITIONS, KITS AND METHODS FOR TREATING TYPE II DIABETES MELLITUS | 2018-05-24 |
| 20180140654 | COMPOSITIONS AND METHODS FOR TREATMENT OF ALCOHOL INDUCED LIVER INJURY | 2018-05-24 |
| 20180140655 | AGENT CONTAINING IMIDAZOLE DIPEPTIDE | 2018-05-24 |
| 20180140656 | SHORT SYNTHETIC PEPTIDE FOR THE TREATMENT AND/OR PROPHYLAXIS OF AUTOIMMUNE AND INFLAMMATORY DISORDERS | 2018-05-24 |
| 20180140657 | COMPOSITIONS AND METHODS FOR TREATING CANCER AND PERSISTENT VIRAL INFECTIONS | 2018-05-24 |
| 20180140658 | A METHOD OF TREATING A WOUND, COMPRISING THE STEP OF ADMINISTERING A COMPOSITION INCLUDING A SUBSTANCE P | 2018-05-24 |
| 20180140659 | ANALOGS OF C5a AND METHODS OF USING SAME | 2018-05-24 |
| 20180140660 | COMPOSITIONS AND METHODS FOR TREATING CANCER | 2018-05-24 |
| 20180140661 | PEPTIDE INHIBITORS OF TWIST | 2018-05-24 |
| 20180140662 | Sustained Release Formulation Comprising Octreotide and Two or More Polylactide-co-glycolide Polymers | 2018-05-24 |
| 20180140663 | FLAGELLIN RELATED POLYPEPTIDES AND USES THEREOF | 2018-05-24 |
| 20180140664 | METHODS, REAGENTS AND KITS FOR DETECTING MINIMAL RESIDUAL DISEASE | 2018-05-24 |
| 20180140665 | IMMUNOMODULATORY & ONCOLYTIC MINICELLS AND METHODS OF USE | 2018-05-24 |
| 20180140666 | FLAGELLIN FUSION PROTEINS AND CONJUGATES COMPRISING PNEUMOCOCCUS ANTIGENS AND METHODS OF USING THE SAME | 2018-05-24 |
| 20180140667 | UBIQUITIN LIGASE KPC1 PROMOTES PROCESSING OF P105 NF-KAPPAB1 TO P50, ELICITING STRONG TUMOR SUPPRESSION | 2018-05-24 |
| 20180140668 | METHODS FOR TREATING RESTENOSIS USING ANNEXIN A5 | 2018-05-24 |
| 20180140669 | COMPOSITIONS AND METHODS FOR ENHANCING PEPTIDE STABILITY AGAINST PROTEASE DIGESTION | 2018-05-24 |
| 20180140670 | COMPOSITIONS, ARTICLES OF MANUFACTURE AND METHODS FOR TREATING CANCER | 2018-05-24 |
| 20180140671 | COMPOSITIONS AND METHODS FOR CARDIAC TISSUE REPAIR | 2018-05-24 |
| 20180140672 | ADMINISTRATION OF GROWTH FACTORS FOR THE TREATMENT OF CNS DISORDERS | 2018-05-24 |
| 20180140673 | FGF21 Derivatives and Uses Thereof | 2018-05-24 |
| 20180140674 | COMBINATION OF TOLEROGENIC PEPTIDES AND TFG-B FOR USE IN THE INDUCTION AND MAINTENANCE OF ORAL TOLERANCE IN YOUNG MAMMALS | 2018-05-24 |
| 20180140675 | Combination Of Dopamine Agonists Plus First Phase Insulin Secretagogues For The Treatment Of Metabolic Disorders | 2018-05-24 |
| 20180140676 | RAPID-ACTING INSULIN COMPOSITIONS | 2018-05-24 |
| 20180140677 | ENHANCED MELANOMA CANCER PREVENTION BY NOVEL MELANOTROPINS | 2018-05-24 |
| 20180140678 | Directed Stem Cell Recruitment | 2018-05-24 |
| 20180140679 | MODULATION OF AXL RECEPTOR ACTIVITY IN COMBINATION WITH CYTOREDUCTIVE THERAPY | 2018-05-24 |
| 20180140680 | NANOREACTOR USING POLYION COMPLEX POLYMERSOMES, AND METHOD FOR PRODUCING SAME | 2018-05-24 |
| 20180140681 | COMPOSITION FOR PREVENTING OR TREATING AUTOIMMUNE DISEASE, CONTAINING SSU72 AS ACTIVE INGREDIENT | 2018-05-24 |
| 20180140682 | GENE EDITING METHODS AND COMPOSITIONS FOR ELIMINATING RISK OF JC VIRUS ACTIVATION AND PML (PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY) DURING IMMUNOSUPPRESSIVE THERAPY | 2018-05-24 |
| 20180140683 | Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract | 2018-05-24 |
| 20180140684 | MODULATION OF MUSCLE AND ADIPOCYTE DISTRIBUTION AND FATE | 2018-05-24 |
| 20180140685 | A NEW THERAPEUTIC USE OF THE BOTULINUM NEUROTOXIN SEROTYPE A | 2018-05-24 |
| 20180140686 | ENZYMATIC IMMUNOMODULATION OF SOLID TUMORS AND USES THEREOF | 2018-05-24 |
| 20180140687 | METABOLIC THERAPY FOR OXIDATIVE STRESS IN THE BRAIN THROUGH TARGETED NEURONAL CATABOLISM OF N-ACETYL-ASPARTIC ACID | 2018-05-24 |
| 20180140688 | PROPIONYL-COA CARBOXYLASE COMPOSITIONS AND USES THEREOF | 2018-05-24 |
| 20180140689 | HUMANIZED ANTIBODIES | 2018-05-24 |
| 20180140690 | LASER-ASSISTED INTRADERMAL ADMINISTRATION OF ACTIVE SUBSTANCES | 2018-05-24 |
| 20180140691 | COMBINATION USE OF WT1 ANTIGEN PEPTIDE AND IMMUNOMODULATOR | 2018-05-24 |
